All news
  • "Regulatory guillotine" of alcohol-containing medicines was launched

    On January 17, a meeting of a working group from the expert and business community on the implementation of the “regulatory guillotine” in the production and turnover of alcoholic beverages took place. Ilya Lomakin-Rumyantsev, Director of the Center for Consumer Market Development at the Moscow School of Management Skolkovo, was elected Chairman of the working group. Olga Pentegova, Deputy Director General of the Association of Russian Pharmaceutical Manufacturers, represents the pharmaceutical industry.

  • ARPM Strategic Plans and Hot Topics for Today

    The transition period for the implementation of drug labeling will be extended by six months. “Medicinal products for medical use manufactured before July 1, 2020 are subject to storage, transportation, dispensing, sale, transfer, use without identification means until the expiration date,” the document says. The amendment adopted in the second reading allows participants in the process to register, test the system and debug business processes. In November, according to Elena Kudryavtseva, deputy head of the Office for Organization of State Quality Control of Medical Products of Federal Service for Surveillance in Healthcare (Roszdravnadzor), the industry’s readiness was 30%...

  • Denis Chetverikov, President of Akrikhin, was elected Chairman of the ARPM Supervisory Board

    On December 4, the annual General Meeting of the Association of Russian Pharmaceutical Manufacturers was held. The event was attended by the leaders of the ARPM member companies, representatives of state authorities, and pharmaceutical market experts.
    Denis Chetverikov, President of Akrikhin, was unanimously elected Chairman of the ARPM Supervisory Board. In his welcoming speech, he thanked his colleagues for their trust and noted that the member companies of the Association are key investors ...

  • Industry readiness for labeling as average hospital temperature

    The Association of Russian Pharmaceutical Manufacturers held a round table “General preparedness for drug labeling” as part of the business program of the Pharmtech & Ingredients 2019 exhibition. The panelists once again discussed the degree of readiness of the industry to launch a drug movement monitoring system (DMM), gave an analysis of the first steps of labeling according to the program, 7 high-cost nosologies and identified problems that need to be addressed.

  • Restart or false start: what scenario will the deputies choose?

    Deputies submitted a bill to the State Duma of the Russian Federation on the phased implementation of drug labeling until July 1, 2020. The text of document No. 834261–7 is published on the portal of draft legal acts. 64 deputies and 3 members of the Federation Council have already joined the initiative.
    The bill says that “medicinal products for medical use intended to provide people with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher disease, malignant neoplasms of lymphoid, hematopoietic and and related tissues, multiple sclerosis, people after transplantation of organs ...

  • Marking: let's bring positions closer

    “There will be no postponement of labeling unless force majeure occurs,” said Irina Golovina, Deputy Director General of the Federal State Budget Institution Information and methodological center for examination, accounting and analysis of circulation of medical devices of Federal Service for Surveillance in Healthcare (Roszdravnadzor), on the sidelines of the pharmaceutical industry digitalization forum on October 28 at the First Sechenov Moscow State Medical University. But at least three such cases have already occurred during the experiment. What the regulator calls force majeure is perceived by business as a hoax!

  • What is happening on the pharmaceutical market of Russia or again about labeling

    On January 1, the drug labeling system in Russia will become mandatory for all market participants, without exception. Every day there is less and less time left until the start, and more questions arise. At round tables, meetings and forums the progress of the experiment and the readiness to implement the system are being discussed. Problems and forecasts were discussed at the international conference “What is happening on the pharmaceutical market”.


All projects

Membership of ARFP in the Organizations

Russian Union of Industrialists
and Entrepreneurs (RSPP)

Chamber of Commerce and Industry (CCI)
of the Russian Federation

Awards of Association

Partners of association